{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:58:15Z","timestamp":1789408695711,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ahj.2006.06.005","type":"journal-article","created":{"date-parts":[[2006,9,8]],"date-time":"2006-09-08T15:17:14Z","timestamp":1157728634000},"page":"493.e1-493.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study"],"prefix":"10.1016","volume":"152","author":[{"given":"Friedrich","family":"Schulze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Lenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hanefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asja","family":"Bartling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Osterziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Goudeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Schmidt-Lucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Kusus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renke","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edzard","family":"Schwedhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Str\u00f6dter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd C.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00fcgge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner G.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Tillmanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Maisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Streichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer H.","family":"B\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2006.06.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(00)01686-0","article-title":"Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox","volume":"478","author":"Tsikas","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ahj.2006.06.005_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0955-0674(93)90080-A","article-title":"Protein methylation","volume":"5","author":"Clarke","year":"1993","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ahj.2006.06.005_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0092-8674(01)00423-8","article-title":"State of the arg: protein methylation at arginine comes of age","volume":"106","author":"McBride","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ahj.2006.06.005_bib4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1476-5381.1996.tb16069.x","article-title":"Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase","volume":"119","author":"MacAllister","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ahj.2006.06.005_bib5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase","volume":"23","author":"Achan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2006.06.005_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.0000105764.22626.B1","article-title":"Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans","volume":"109","author":"Kielstein","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2006.06.005_bib7","first-page":"193","article-title":"Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers","volume":"7","author":"Calver","year":"1993","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ahj.2006.06.005_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","article-title":"Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension","volume":"33","author":"Surdacki","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2006.06.005_bib9","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","author":"B\u00f6ger","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2006.06.005_bib10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","article-title":"Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor","volume":"287","author":"St\u00fchlinger","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2006.06.005_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0008-6363(02)00617-X","article-title":"ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of l-arginine and B vitamins","volume":"57","author":"Sydow","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2006.06.005_bib12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/oxfordjournals.ndt.a027213","article-title":"Concentration of dimethyl-l-arginine in the plasma of patients with end-stage renal failure","volume":"11","author":"MacAllister","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ahj.2006.06.005_bib13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","article-title":"Asymmetrical dimethylarginine: the Uber marker?","volume":"109","author":"Cooke","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2006.06.005_bib14","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase predicts mortality in end-stage renal disease (ESRD)","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2006.06.005_bib15","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ehj.2003.08.013","article-title":"Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention","volume":"24","author":"Lu","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2006.06.005_bib16","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/01.RES.0000181286.44222.61","article-title":"Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary heart disease. Results from the AtheroGene Study","volume":"97","author":"Schnabel","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2006.06.005_bib17","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2006.06.005_bib18","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The l-arginine\u2013nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2006.06.005_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/clc.4960261006","article-title":"Asymmetrical dimethylarginine: a novel risk factor for coronary heart disease","volume":"26","author":"Lu","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2006.06.005_bib20","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.eururo.2005.07.017","article-title":"Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction","volume":"48","author":"Maas","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ahj.2006.06.005_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2005.05.002","article-title":"Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease","volume":"184","author":"Wang","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2006.06.005_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1567-5688(03)00031-X","article-title":"Plasma concentration of asymmetric dimethylarginine and the risk of coronary heart disease: rationale and design of the multicenter CARDIAC study","volume":"4","author":"M\u00fcgge","year":"2003","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.ahj.2006.06.005_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1515\/CCLM.2004.257","article-title":"Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay","volume":"42","author":"Schulze","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ahj.2006.06.005_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2362.2005.01561.x","article-title":"Determination of a reference value for N(G), N(G)-dimethyl-l-arginine in 500 subjects","volume":"35","author":"Schulze","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ahj.2006.06.005_bib25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2006.06.005_bib26","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1177\/1358836X0501000113","article-title":"Quantification of ADMA: analytical approaches","volume":"10","author":"Schwedhelm","year":"2005","journal-title":"Vasc Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870306005515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870306005515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:27:44Z","timestamp":1757568464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870306005515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0002870306005515"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2006.06.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1065842.518783","asserted-by":"object"}]},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2006.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}